GAO vets DMEPOS oversight
This article was originally published in The Gray Sheet
A 1Sept. 22 report from the Government Accountability Office finds that efforts by a CMS contractor are insufficient to prevent Medicare fraud by medical equipment suppliers. Licensure checks by the contractor, National Supplier Clearinghouse, are ineffective because they rely on "self-reported information about the items suppliers intend to provide to beneficiaries and [do] not match this against actual billing later," GAO writes. In addition, NSC overlooks too many suppliers in its on-site inspection program. GAO urges CMS to strengthen its supervision of the NSC anti-fraud program, which affects suppliers of durable medical equipment, prosthetics, orthotics and other supplies...
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.